Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 4:12 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1897–1920 of 2,761 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: High Activity Clear all

Conditions: Major Depressive Disorder, Depression
Interventions: Cognitive Behavioral Therapy (CBT), Active Whole-Body Hyperthermia (Active WBH), Sham Whole-Body Hyperthermia (Sham WBH); Behavioral · Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Stroke, Motor Function
Interventions: Repetitive Transcranial Magnetic Stimulation (rTMS), Transcranial Direct Current Stimulation (tDCS); Device
Lead sponsor: Spaulding Rehabilitation Hospital; Other
Eligibility: 18 Years to 90 Years
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Carcinoma, Intraductal, Noninfiltrating
Interventions: Pembrolizumab, Intralesional mRNA 2752; Drug · Biological
Lead sponsor: Laura Esserman; Other
Eligibility: 18 Years and older · Female only
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2026
U.S. locations: 1
States / cities: San Francisco, California

Conditions: HIV Infections
Interventions: Couples HIV testing and counseling, Individual HIV testing and counseling; Behavioral
Lead sponsor: Hunter College of City University of New York; Other
Eligibility: 17 Years to 65 Years · Male only
Enrollment: 384 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 2
States / cities: Ann Arbor, Michigan • New York, New York

Conditions: Healthy
Interventions: Hatha Yoga Classes, Movement Control; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 30 Years to 65 Years · Female only
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Chronic Kidney Diseases
Interventions: High-Velocity Resistance Training, Attention; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 65 Years to 100 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Neurologic Disorder, Stroke, Spinal Cord Injuries, Cerebral Palsy, Hemiplegia, Hemiparesis, Multiple Sclerosis, Parkinson Disease, Trauma, Brain, Transverse Myelitis, Friedreich Ataxia
Interventions: Seated exercise; Behavioral
Lead sponsor: Burke Medical Research Institute; Other
Eligibility: 18 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: White Plains, New York

Conditions: Parkinson's Disease, Depression
Interventions: Repetitive transcranial magnetic stimulation (rTMS); Device
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 21 Years to 85 Years
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 5
States / cities: Los Angeles, California • Gainesville, Florida • Boston, Massachusetts + 2 more

Conditions: Peritonitis
Interventions: duration of antibiotics; Other
Lead sponsor: University of Virginia; Other
Eligibility: 16 Years and older
Enrollment: 518 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 22
States / cities: Phoenix, Arizona • Sacramento, California • San Diego, California + 17 more

Conditions: Parkinson Disease, Deep Brain Stimulation
Interventions: Forced and Voluntary Exercise; Other
Lead sponsor: Jay Alberts; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Chronic Fatigue Syndrome
Interventions: Exercise test; Behavioral
Lead sponsor: Stony Brook University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Posterior Tibial Tendon Dysfunction
Interventions: Bracing, Strengthening exercises, Stretching exercises; Device · Other
Lead sponsor: Ithaca College; Other
Eligibility: 40 Years to 80 Years
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Colorectal Cancer, Cancer, Rectum Cancer, Colon Cancer
Interventions: mPATH-CRC, mPATH-Checkin, "high touch" Implementation strategy, "low touch" Implementation Strategy; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 77,145 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Pain, Postoperative
Interventions: Brivoligide Injection 660 mg/6 mL, Placebo 6 mL; Drug
Lead sponsor: Adynxx, Inc.; Industry
Eligibility: 40 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: Sheffield, Alabama • Phoenix, Arizona

Conditions: Palmar Hyperhidrosis
Interventions: Dexmecamylamine HCl, Placebo; Drug · Other
Lead sponsor: Atacama Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 3
States / cities: San Diego, California • St Louis, Missouri • Norfolk, Virginia

Conditions: Multiple Sclerosis
Interventions: Anakinra; Drug
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 120 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Attention Deficit Hyperactivity Disorder (ADHD), Impulsive Aggression
Interventions: Functional Magnetic Resonance Imaging (fMRI), Magnetic Resonance Spectroscopy (MRS), Point Subtraction Aggression Paradigm (PSAP) Task, SPN-810, Placebo; Diagnostic Test · Behavioral · Drug
Lead sponsor: Supernus Pharmaceuticals, Inc.; Industry
Eligibility: 8 Years to 12 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 3
States / cities: Lakeland, Florida • Maitland, Florida • Tampa, Florida

Conditions: Weight Loss, Bone Density
Interventions: Caloric restriction, high protein, Caloric restriction; normal protein, Counseling; Behavioral
Lead sponsor: Rutgers University; Other
Eligibility: 50 Years to 70 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Normal Physiology
Interventions: In vivo MRS, fMRI, EEG/EOG, Stimulation tasks, NSPRD, Structural MRI; Other
Lead sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA); NIH
Eligibility: 18 Years and older
Enrollment: 57 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Small Cell Lung Cancer
Interventions: Fenretinide; Drug
Lead sponsor: SciTech Development, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: Los Angeles, California • Detroit, Michigan

Conditions: Psoriasis
Interventions: BI 655066, Ustekinumab; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 166 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 12
States / cities: Los Angeles, California • Port Orange, Florida • Arlington Hts, Illinois + 9 more

Conditions: Heart Failure With Preserved Ejection Fraction
Interventions: High Intensity Interval Exercise, Dietary Approaches to Stop Hypertension (DASH) Diet, Exercise + DASH Diet; Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 40 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Exercise
Interventions: Placebo, HMB-FA, High Intensity Interval Training; Dietary Supplement · Procedure
Lead sponsor: Metabolic Technologies Inc.; Industry
Eligibility: 18 Years to 35 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Coronary Artery Disease
Interventions: EDTA, EDTA Placebo, High Dose Vitamin, High Dose Vitamin Placebo; Drug · Dietary Supplement
Lead sponsor: Mt. Sinai Medical Center, Miami; Other
Eligibility: 50 Years and older
Enrollment: 1,708 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2012
U.S. locations: 73
States / cities: Little Rock, Arkansas • Danville, California • Fresno, California + 68 more

Search by objective public record fields.

HypErthermia as an Additional Treatment for the Biology and Experience of Depression: Study 2

Effects of rTMS and tDCS on Motor Function in Stroke

Immunotherapy in High-risk Ductal Carcinoma in Situ (DCIS)

Evaluating the Efficacy of Annual CHTC Retesting Among Male Couples at High Risk of HIV Infection

Yoga, Immune Function, and Health

Enhancing Physical Function in Older Adults With Chronic Kidney Disease

Home Based Tele-exercise for People With Chronic Neurological Impairments

rTMS for Motor and Mood Symptoms of Parkinson's Disease

SIS Multicenter Study of Duration of Antibiotics for Intraabdominal Infection

The Impact of Exercise on Subthalamic Nucleus Neural Activity in Parkinson's Disease

Exercise-related Post-exertional Malaise

Bracing and Strengthening for Posterior Tibial Tendon Dysfunction

Effectiveness and Implementation of mPATH-CRC

Study to Evaluate a Preop Dose of Brivoligide Injection for Pain After Knee Replacement in Patients With High PCS Scores

Exploratory Study to Assess the Efficacy and Safety of TC-5214 in the Treatment of Subjects With Palmar Hyperhidrosis

Anakinra for the Treatment of Chronically Inflamed White Matter Lesions in Multiple Sclerosis

Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With ADHD

The Effect of Weight Loss and Dietary Protein Intake on Bone

Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer

BI 655066 Dose Ranging in Psoriasis, Active Comparator Ustekinumab

The Effect of a High Fiber Diet and High-Intensity Interval Exercise in Patients With HFpEF

The Effects of β-Hydroxy-β-methylbutyrate Free Acid and High-Intensity Interval Training

Trial to Assess Chelation Therapy (TACT)